nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—Dimetacrine—Tamoxifen—pancreatic cancer	0.285	0.571	CrCrCtD
Triflupromazine—Promazine—Tamoxifen—pancreatic cancer	0.214	0.429	CrCrCtD
Triflupromazine—BCHE—Irinotecan—pancreatic cancer	0.143	0.376	CbGbCtD
Triflupromazine—ABCB1—Tamoxifen—pancreatic cancer	0.0474	0.124	CbGbCtD
Triflupromazine—ABCB1—Gemcitabine—pancreatic cancer	0.0408	0.107	CbGbCtD
Triflupromazine—ABCB1—Erlotinib—pancreatic cancer	0.0403	0.106	CbGbCtD
Triflupromazine—ABCB1—Irinotecan—pancreatic cancer	0.0364	0.0954	CbGbCtD
Triflupromazine—ABCB1—Docetaxel—pancreatic cancer	0.0267	0.0699	CbGbCtD
Triflupromazine—ABCB1—Sunitinib—pancreatic cancer	0.0266	0.0696	CbGbCtD
Triflupromazine—ABCB1—Doxorubicin—pancreatic cancer	0.0199	0.0521	CbGbCtD
Triflupromazine—DRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.78e-05	0.000233	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	2.76e-05	0.000232	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CG—pancreatic cancer	2.74e-05	0.00023	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	2.73e-05	0.000229	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GCG—pancreatic cancer	2.73e-05	0.000229	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—APOE—pancreatic cancer	2.72e-05	0.000228	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	2.72e-05	0.000228	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TERT—pancreatic cancer	2.7e-05	0.000226	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	2.68e-05	0.000225	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CXCL8—pancreatic cancer	2.67e-05	0.000224	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GCG—pancreatic cancer	2.67e-05	0.000224	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.65e-05	0.000222	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	2.65e-05	0.000222	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GCG—pancreatic cancer	2.63e-05	0.000221	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AGTR1—pancreatic cancer	2.6e-05	0.000218	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.6e-05	0.000218	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HIF1A—pancreatic cancer	2.58e-05	0.000216	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.58e-05	0.000216	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TSC2—pancreatic cancer	2.57e-05	0.000216	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—STK11—pancreatic cancer	2.56e-05	0.000215	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.56e-05	0.000215	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	2.55e-05	0.000213	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TERT—pancreatic cancer	2.55e-05	0.000213	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—APOE—pancreatic cancer	2.52e-05	0.000211	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	2.51e-05	0.000211	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—STK11—pancreatic cancer	2.51e-05	0.00021	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—STK11—pancreatic cancer	2.48e-05	0.000208	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—KDR—pancreatic cancer	2.47e-05	0.000207	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.46e-05	0.000206	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CG—pancreatic cancer	2.46e-05	0.000206	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HIF1A—pancreatic cancer	2.43e-05	0.000204	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TSC2—pancreatic cancer	2.43e-05	0.000203	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CD—pancreatic cancer	2.41e-05	0.000202	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—APOE—pancreatic cancer	2.38e-05	0.000199	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PPARG—pancreatic cancer	2.37e-05	0.000199	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.36e-05	0.000198	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NFKBIA—pancreatic cancer	2.35e-05	0.000197	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—KDR—pancreatic cancer	2.33e-05	0.000195	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	2.33e-05	0.000195	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NOTCH1—pancreatic cancer	2.33e-05	0.000195	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.31e-05	0.000194	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CG—pancreatic cancer	2.27e-05	0.000191	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—NRAS—pancreatic cancer	2.27e-05	0.000191	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.26e-05	0.00019	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EGF—pancreatic cancer	2.25e-05	0.000188	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SMAD4—pancreatic cancer	2.25e-05	0.000188	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.23e-05	0.000187	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCL8—pancreatic cancer	2.22e-05	0.000186	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NFKBIA—pancreatic cancer	2.21e-05	0.000186	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	2.2e-05	0.000184	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HES1—pancreatic cancer	2.19e-05	0.000184	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOTCH1—pancreatic cancer	2.19e-05	0.000184	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.17e-05	0.000182	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	2.17e-05	0.000182	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CD—pancreatic cancer	2.16e-05	0.000181	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	2.15e-05	0.00018	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HES1—pancreatic cancer	2.15e-05	0.00018	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CG—pancreatic cancer	2.14e-05	0.00018	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—NRAS—pancreatic cancer	2.14e-05	0.00018	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EGF—pancreatic cancer	2.12e-05	0.000178	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HES1—pancreatic cancer	2.12e-05	0.000178	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CD44—pancreatic cancer	2.11e-05	0.000176	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CB—pancreatic cancer	2.1e-05	0.000176	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—EGFR—pancreatic cancer	2.07e-05	0.000174	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.06e-05	0.000172	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	2.03e-05	0.00017	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GCG—pancreatic cancer	2.02e-05	0.000169	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCL8—pancreatic cancer	2.02e-05	0.000169	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CD—pancreatic cancer	2e-05	0.000167	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.98e-05	0.000166	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	1.98e-05	0.000165	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—KRAS—pancreatic cancer	1.96e-05	0.000164	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—EGFR—pancreatic cancer	1.95e-05	0.000164	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	1.95e-05	0.000163	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TERT—pancreatic cancer	1.92e-05	0.000161	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—STK11—pancreatic cancer	1.9e-05	0.000159	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CD—pancreatic cancer	1.89e-05	0.000158	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CB—pancreatic cancer	1.88e-05	0.000158	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TERT—pancreatic cancer	1.88e-05	0.000158	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.87e-05	0.000156	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTGS2—pancreatic cancer	1.87e-05	0.000156	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TERT—pancreatic cancer	1.86e-05	0.000156	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—KRAS—pancreatic cancer	1.85e-05	0.000155	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	1.84e-05	0.000154	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TSC2—pancreatic cancer	1.83e-05	0.000154	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	1.8e-05	0.000151	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.8e-05	0.000151	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	1.79e-05	0.00015	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOE—pancreatic cancer	1.79e-05	0.00015	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	1.78e-05	0.000149	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	1.77e-05	0.000148	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KDR—pancreatic cancer	1.76e-05	0.000147	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOE—pancreatic cancer	1.76e-05	0.000147	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CB—pancreatic cancer	1.74e-05	0.000146	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOE—pancreatic cancer	1.73e-05	0.000145	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KDR—pancreatic cancer	1.72e-05	0.000144	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KDR—pancreatic cancer	1.7e-05	0.000142	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.7e-05	0.000142	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL8—pancreatic cancer	1.67e-05	0.00014	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	1.67e-05	0.00014	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—HRAS—pancreatic cancer	1.66e-05	0.000139	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	1.66e-05	0.000139	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CB—pancreatic cancer	1.64e-05	0.000138	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	1.64e-05	0.000137	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—TYMS—pancreatic cancer	1.63e-05	0.000137	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTEN—pancreatic cancer	1.63e-05	0.000136	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	1.62e-05	0.000136	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	1.62e-05	0.000136	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	1.62e-05	0.000136	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AKT1—pancreatic cancer	1.62e-05	0.000136	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	1.62e-05	0.000135	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CASP3—pancreatic cancer	1.6e-05	0.000134	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGF—pancreatic cancer	1.6e-05	0.000134	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	1.6e-05	0.000134	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	1.58e-05	0.000133	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	1.58e-05	0.000133	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL8—pancreatic cancer	1.58e-05	0.000132	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HRAS—pancreatic cancer	1.57e-05	0.000131	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGF—pancreatic cancer	1.57e-05	0.000131	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	1.56e-05	0.000131	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	1.56e-05	0.000131	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCND1—pancreatic cancer	1.56e-05	0.000131	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	1.55e-05	0.00013	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CTNNB1—pancreatic cancer	1.54e-05	0.000129	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AKT1—pancreatic cancer	1.53e-05	0.000128	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MMP9—pancreatic cancer	1.51e-05	0.000127	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CASP3—pancreatic cancer	1.51e-05	0.000127	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PTEN—pancreatic cancer	1.51e-05	0.000126	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	1.48e-05	0.000124	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCND1—pancreatic cancer	1.47e-05	0.000123	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AKT1—pancreatic cancer	1.47e-05	0.000123	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CTNNB1—pancreatic cancer	1.46e-05	0.000122	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.44e-05	0.000121	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MMP9—pancreatic cancer	1.43e-05	0.00012	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	1.43e-05	0.000119	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	1.42e-05	0.000119	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PTEN—pancreatic cancer	1.42e-05	0.000119	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.41e-05	0.000118	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SRC—pancreatic cancer	1.4e-05	0.000117	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	1.39e-05	0.000117	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.39e-05	0.000117	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AKT1—pancreatic cancer	1.39e-05	0.000116	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.38e-05	0.000116	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	1.38e-05	0.000115	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.36e-05	0.000114	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.36e-05	0.000114	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—VEGFA—pancreatic cancer	1.36e-05	0.000114	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—STAT3—pancreatic cancer	1.35e-05	0.000113	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	1.35e-05	0.000113	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NRAS—pancreatic cancer	1.34e-05	0.000113	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOE—pancreatic cancer	1.33e-05	0.000111	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SRC—pancreatic cancer	1.32e-05	0.00011	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—VEGFA—pancreatic cancer	1.28e-05	0.000107	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.28e-05	0.000107	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—STAT3—pancreatic cancer	1.27e-05	0.000106	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NRAS—pancreatic cancer	1.27e-05	0.000106	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.25e-05	0.000105	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MYC—pancreatic cancer	1.25e-05	0.000105	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFB1—pancreatic cancer	1.25e-05	0.000105	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	1.24e-05	0.000104	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.24e-05	0.000104	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EGFR—pancreatic cancer	1.22e-05	0.000103	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.21e-05	0.000102	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.2e-05	0.0001	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	1.2e-05	0.0001	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	1.19e-05	9.99e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	1.18e-05	9.92e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MYC—pancreatic cancer	1.18e-05	9.89e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFB1—pancreatic cancer	1.18e-05	9.86e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.17e-05	9.78e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.16e-05	9.71e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARG—pancreatic cancer	1.16e-05	9.69e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—KRAS—pancreatic cancer	1.16e-05	9.69e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EGFR—pancreatic cancer	1.15e-05	9.67e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	1.15e-05	9.65e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	1.15e-05	9.65e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CA—pancreatic cancer	1.15e-05	9.61e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	1.14e-05	9.59e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	1.14e-05	9.56e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	1.13e-05	9.44e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	1.12e-05	9.36e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	1.11e-05	9.32e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	1.11e-05	9.31e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	1.1e-05	9.24e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	1.1e-05	9.22e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—KRAS—pancreatic cancer	1.09e-05	9.13e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	1.09e-05	9.11e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	1.08e-05	9.03e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	1.08e-05	9.02e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	1.07e-05	8.99e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	1.07e-05	8.98e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	1.06e-05	8.9e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	1.06e-05	8.9e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	1.06e-05	8.84e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.05e-05	8.83e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	1.05e-05	8.79e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	1.05e-05	8.76e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	1.04e-05	8.73e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	1.04e-05	8.68e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TP53—pancreatic cancer	1.03e-05	8.61e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.02e-05	8.58e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	1.01e-05	8.47e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	1e-05	8.39e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SRC—pancreatic cancer	9.94e-06	8.33e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	9.83e-06	8.23e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	9.73e-06	8.15e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TP53—pancreatic cancer	9.69e-06	8.12e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	9.68e-06	8.11e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	9.6e-06	8.05e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	9.59e-06	8.03e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	9.56e-06	8.01e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	9.48e-06	7.94e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	9.38e-06	7.86e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AKT1—pancreatic cancer	9.37e-06	7.85e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	9.36e-06	7.84e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	9.35e-06	7.84e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	9.27e-06	7.76e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	9.26e-06	7.76e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	9.24e-06	7.74e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	9.18e-06	7.69e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS2—pancreatic cancer	9.1e-06	7.62e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MYC—pancreatic cancer	8.91e-06	7.46e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	8.89e-06	7.45e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	8.72e-06	7.3e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	8.71e-06	7.3e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	8.7e-06	7.29e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	8.68e-06	7.27e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	8.61e-06	7.21e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	8.59e-06	7.19e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	8.53e-06	7.14e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	8.42e-06	7.05e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	8.23e-06	6.9e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	8.18e-06	6.86e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	8.06e-06	6.75e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	7.95e-06	6.66e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTEN—pancreatic cancer	7.94e-06	6.65e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	7.56e-06	6.34e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	7.4e-06	6.2e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TP53—pancreatic cancer	7.32e-06	6.13e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	7.31e-06	6.12e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	7.16e-06	6e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	7.07e-06	5.92e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	7e-06	5.86e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	6.85e-06	5.74e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	6.76e-06	5.66e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	6.18e-06	5.18e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	6.05e-06	5.07e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	5.97e-06	5e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	5.6e-06	4.69e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKT1—pancreatic cancer	4.57e-06	3.83e-05	CbGpPWpGaD
